Dr. Hector A Dox, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 255 Baptist Blvd Ste 401, Columbus, MS 39705 Phone: 662-244-2288 Fax: 662-244-2289 |
Edward Frank Crocker Jr., M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 255 Baptist Blvd, Suite 401, Columbus, MS 39705 Phone: 662-244-2288 Fax: 662-244-2289 |
Dr. William Stewart Horsley, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 255 Baptist Blvd Ste 401, Columbus, MS 39705 Phone: 662-244-2288 Fax: 662-244-2289 |
News Archive
Sandwiches make up a substantial part of the American diet and are a significant contributor to daily energy and sodium intake. By closely analyzing data from the federal nationwide dietary intake survey known as "What We Eat in America NHANES 2009-2010," a team of Department of Agriculture researchers found that on any given day 49 percent of U.S. adults eat at least one sandwich, and sandwiches account for one-fifth of total daily sodium intake.
Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing, co-led by new investors Cormorant Asset Management, Hillhouse Capital Group and venBio Global Strategic Fund, joining existing investors Morningside Venture Investments, AJU IB Investment, and Epidarex Capital.
Lexicon Pharmaceuticals, Inc. today announced the completion of its previously-announced public offering of shares of its common stock. The offering included an aggregate of 38,333,332 shares of Lexicon's common stock after the exercise in full by the underwriters of their over-allotment option and by Invus, L.P., Lexicon's largest stockholder, of its associated right to purchase additional shares.
The Translational Genomics Research Institute (TGen) and George Mason University today announced the creation of a strategic research alliance to benefit patients with cancer and other life-threatening illnesses.
A scientific team from Case Western Reserve University School of Medicine and Cleveland Clinic has developed a new way to identify second-line antibiotics that may be effective in killing germs already resistant to a first-line antibiotic - potentially helping overcome antibiotic resistance.
› Verified 9 days ago